1. Home
  2. EH vs ENTA Comparison

EH vs ENTA Comparison

Compare EH & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EHang Holdings Limited ADS

EH

EHang Holdings Limited ADS

N/A

Current Price

$2.91

Market Cap

257.9M

Sector

Industrials

ML Signal

N/A

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

N/A

Current Price

$8.20

Market Cap

303.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EH
ENTA
Founded
2014
1995
Country
China
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
257.9M
303.8M
IPO Year
2019
2012

Fundamental Metrics

Financial Performance
Metric
EH
ENTA
Price
$2.91
$8.20
Analyst Decision
Buy
Strong Buy
Analyst Count
10
6
Target Price
$7.83
★ $21.83
AVG Volume (30 Days)
★ 651.2K
258.3K
Earning Date
11-30-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 38.80
EPS
★ N/A
N/A
Revenue
N/A
★ $102,814,000.00
Revenue This Year
$1.85
$1.73
Revenue Next Year
$70.64
$34.79
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 16.48
52 Week Low
$3.28
$8.31
52 Week High
$15.27
$17.15

Technical Indicators

Market Signals
Indicator
EH
ENTA
Relative Strength Index (RSI) 29.09 28.05
Support Level N/A N/A
Resistance Level $4.27 $13.94
Average True Range (ATR) 0.27 0.86
MACD -0.07 -0.26
Stochastic Oscillator 2.10 8.27

Price Performance

Historical Comparison
EH
ENTA

About EH EHang Holdings Limited ADS

EHang Holdings Ltd is an urban air mobility (UAM) technology platform company focused on autonomous aerial vehicle technology and solutions. The company provides unmanned aerial vehicle (UAV) systems and solutions for air mobility, including passenger transportation and logistics, as well as smart city management and aerial media solutions. Its EH216-S passenger-carrying pilotless eVTOL aircraft has obtained a production certificate and standard airworthiness certificate from the Civil Aviation Administration of China (CAAC).

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: